Results 61 to 70 of about 1,514 (136)

A Multifaceted Holistic Review of the Literature on Scar Dermatoses

International Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury, Elias El Tayar, Edward Eid, Firas F. Haddad, Ossama Abbas, Mazen Kurban   +5 more
wiley   +1 more source

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 186-198, April 2026.
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan, Jianguo Sun, Makoto Kawashima, You Chan Kim, Mison Chun, Chia‐Yu Chu, Yi‐Hsin Liang, Mee Chang, Delphine Kerob, Brigitte Dreno   +9 more
wiley   +1 more source

Amitriptyline Induced Life‐Threatening Steven–Johnson Syndrome: Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Stevens–Johnson syndrome is one of the few dermatological emergencies in clinical practice. The syndrome is often secondary to the usage of drugs, of which allopurinol, penicillins, sulfa drugs, ibuprofen, sodium valproate, phenytoin, lamotrigine, and carbamazepine are commonly implicated.
Wondwosen Mengist Dereje, Lidya Yalew, Nardos Tafesse, Teklegiorgis Goshime Getachew   +3 more
wiley   +1 more source

Bullous Pemphigoid in Children: Sustained 8‐Year Remission After Short‐Course Corticosteroid Therapy

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT This article reports a case of bullous pemphigoid (BP) in a 5‐year‐old child who achieved sustained remission for up to 8 years following short‐course systemic corticosteroid therapy, aiming to provide observational evidence for the clinical management of childhood BP. The child initially presented with pruritic rashes and blisters, which were
Fengchang Wang, Hongxia Li, Yue Xu, Wenge Wang   +3 more
wiley   +1 more source

Generalized bullous fixed drug eruption mimicking Stevens-Johnson syndrome: a case report

International Journal of Community Medicine and Public Health
Bullous fixed drug eruption (BFDE) is a rare but severe cutaneous adverse drug reaction that may mimic Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Geeva Prabhakran Ganesan, J. Sundar, S. Kalpana, S. Valarmathi, G. Srinivas   +4 more
semanticscholar   +1 more source

Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment

Clinical and Translational Science, Volume 18, Issue 12, December 2025.
ABSTRACT Breast cancer is among the most common cancers in U.S. women. Epidermal growth factor receptor inhibitors (EGFRIs) target pathways driving tumor growth but frequently cause dermatologic toxicities that impact quality of life and treatment adherence.
Tvisha Devireddy, Clara Lim, Jhillika Patel, Isabella J. Tan, Bernard A. Cohen   +4 more
wiley   +1 more source

Generalized Bullous Fixed Drug Eruption Associated with Cetirizine and Hydroxyzine Demonstrated by Patch Test

TURKDERM, 2011
Fixed drug eruption (FDE) is characterized by solitary erythematous macules, edematous plaques and bullous lesions that occur at the same place with recurrent exposure to a drug. Though more than 100 drugs have been implicated in leading to FDE, this side effect is more commonly caused by tetracyclines, sulfonamides, sulfone, penicillins, pyrazolones ...
Arslan, Şafak, Taşlı, Levent, Kaçar, Nida, Ergin, Şeniz   +3 more
openaire   +3 more sources

Rare Wound: Extensive Skin Lesions and Poor Wound Healing of the Calf in a Patient With Behçet's Disease

International Wound Journal, Volume 23, Issue 2, February 2026.
Xian Sun, Yang Xia, Jia‐Jun Wu, Ke‐Jia Li   +3 more
wiley   +1 more source

Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting

Frontiers in Allergy
IntroductionCutaneous immune-mediated adverse drug reactions are more prevalent in people with human immunodeficiency virus (PWH). Severe cutaneous adverse drug reactions (SCAR) are a life-threatening subset of cutaneous adverse drug reactions (CADRs ...
S. P. P. Konyana, N. F. Teixeira, L. Pirjol, B. Thwala, W. Nkoyane, M. Porter, F. Gxolo, E. Phillips, E. Phillips, R. Lehloenya, A. Mankahla, J. Peter   +11 more
doaj   +1 more source

A case of generalized bullous fixed drug eruptions induced by ceftriaxone

International Journal of Basic & Clinical Pharmacology
Fixed drug eruption (FDE) is a delayed-type hypersensitivity reaction to a systemic medication. Generalized bullous fixed drug eruption (GBFDE) is a rare variant involving generalized bullae and erosions across multiple anatomical sites. A 66-year-old female with dialysis-dependent chronic kidney disease presented with fever and chills, and ...
Trushti Rathva, Anita Sinha, Vaibhav Solanki, Dilip Kanjariya   +3 more
openaire   +1 more source